CIK 0001469443 · Non-accelerated filer<br>Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810571538
- Phone
- 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-23 | Rey Eric J. Director | Sale | −5,000 | $33.44 | $167K | 7,335 |
| 2018-03-23 | Rey Eric J. Director | Option exercise · Employee Stock Option (right to buy) | −5,000 | 30,719 | ||
| 2018-03-23 | Lu Zhongjin VP Product Development | Option exercise | +1,750 | $21.60 | $38K | 2,308 |
| 2018-03-23 | Lu Zhongjin VP Product Development | Sale | −1,750 | $32.74 | $57K | 558 |
| 2018-03-23 | Lu Zhongjin VP Product Development | Option exercise · Employee Stock Option (right to buy) | −1,750 | 10,438 | ||
| 2018-03-19 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 7 of 7 · 126 trades